Cannabis Law Report

DECEMBER 2, 2021

IGC) is excited to present preliminary positive secondary end point findings from its Phase 1 clinical trial for IGC-AD1. The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021.

Clinical Trials 52

Clinical Trials Data Patients THC 52

The Cannigma

FEBRUARY 2, 2021

In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. However, the survey also revealed that, among the Parkinson’s disease patients , there was a noticeable knowledge gap concerning the different methods of consumption available and the individual effects of THC and CBD.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Cannabis Law Report

OCTOBER 15, 2021

At ASHG, Goldfinch Bio will give an oral presentation showcasing insights revealed by its Kidney Genome Atlas (KGA). At ASHG, Goldfinch Bio will give an oral presentation showcasing insights revealed by its Kidney Genome Atlas (KGA). DNA variations or polymorphisms) in patients with African ancestry.

Clinical Trials 52

Clinical Trials Research and Development Data Patients 52

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. Written by Dr. Meredith Fisher-Corn, MD , Editor-in-Chief at TheAnswerPage.com.

Patients 98

Patients Education Marijuana Therapy 98

United Patients Group

JANUARY 4, 2024

As we move forward into 2024 and beyond, the sector offers diverse paths beyond direct patient care. The growth stems from rising healthcare demand, facility expansion, and the imperative for efficient administration to maintain quality patient care. Adverse drug events (ADEs) affect approximately 7 per 100 hospitalized patients.

Research and Development 52

Research and Development Patients Data Policy 52

Cannabis Law Report

AUGUST 5, 2019

France is searching for patients to take part in an official medical cannabis trial, but users will not be smoking the drug. Patients with muscle spasms related to multiple sclerosis are also invited to take part. If you wish to re-publish this story please do so with following accreditation. AUTHOR: Mark Taylor.

Medicine 60

Medicine Patients Digestion Epilepsy 60

Cannabis Law Report

AUGUST 3, 2021

Unlike most other ailments, there isn’t a simple test that physicians can use to diagnose a patient with a disorder. CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. (CSE: Source: Data Bridge.

Research and Development 105

Research and Development Data Conditions Therapy 105

Project CBD

AUGUST 6, 2019

Over 200 scientists from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpiblished data. CBD for hypertension. Related story Can CBD Help Your Condition? Preclinical promise.

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

Cannabis Law Report

JANUARY 6, 2022

This blog post will explain how psilocybin patenting and other factors could make Oregon’s psilocybin program prohibitively expensive for low-income patients, and how big pharma is maneuvering to monopolize psychedelic therapy. The FDA will likely refer to this data as it considers formal approval for psilocybin therapy and products.

Access 52

Access Patients Research and Development Treatment 52

Illinois News Joint

JANUARY 30, 2023

The new website includes dropdown menus for information about CROO Media , Research and Data , Legal and Enforcement , About , and Agencies. The Media information includes Press Releases, Newsletters, Reports and Public Presentations, and Upcoming Dates. To qualify and receive a medical patient card at a discounted rate, visit here.

Media 86

Media Data Agriculture Recreational 86

Cannabis Chronicles

MAY 22, 2019

SPOKANE — Researchers at Washington State University are teaming up with the Puyallup Tribe of Indians in an effort to chart the tribe’s outcomes prescribing medicinal marijuana to patients. This partnership with WSU and Qwibil will help us research the safety and efficacy of cannabis as medicine for our patients’ use.”.

Medicine 140

Medicine Research and Development Data Collective 140

Veriheal

NOVEMBER 21, 2023

Quemarr presents an emulsion-based drug delivery system tailored for cannabinoids and made to tackle America’s diabetes crisis. Quemarr’s transformative approach to diabetes treatment offers patients a less intrusive alternative to conventional insulin treatments.

Research and Development 106

Research and Development Consumption Education Data 106

Project CBD

AUGUST 6, 2019

Just over 500 participants from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpublished data. CBD for hypertension. Related story Can CBD Help Your Condition?

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

The Joint Blog

MARCH 2, 2020

According to a new study published in the journal Trauma Surgery & Acute Care , trauma patients who are administered THC capsules consume fewer opioids than do similarly matched control subjects. 66 patients participated in the study: Half received THC, and the other half did not. hours from admission minus 0–48?hours

Patients 47

Patients THC Consumption Data 47

Veriheal

AUGUST 22, 2023

Ortega’s research meticulously analyzed data from ten states where adult-use cannabis has become legal. The data revealed that shortly after the adoption of recreational marijuana laws, states began to see fewer admissions to treatment centers for mental illness. This downward trend did not apply to a specific demographic.

Treatment 98

Treatment Legalization Policy Recreational 98

Project CBD

AUGUST 9, 2023

In accordance with longstanding ICRS policy, all speakers presented new findings and data that had not yet been published in a peer-reviewed journal. John Patrick Neary and a team of scientists in Western Canada examined CBD’s impact on 3 female patients who suffered from post-concussion syndrome. CBD for psychosis.

Cannabinoids 180

Cannabinoids THC CBD Blood Pressure 180

TheAnswerPage

JULY 19, 2022

Have researchers found that patients who use cannabidiol (CBD)-rich extract therapy for the treatment of epilepsy require a lower dose of CBD medication as compared to those who use purified CBD therapy for the treatment of epilepsy? Pamplona F, da Silva L and Coan A. 12 September 2018. Sec.Neuropharmacology. See the Answer.

Epilepsy 52

Epilepsy Therapy Extraction Data 52

The Joint Blog

OCTOBER 6, 2019

According to a new study published in the journal Pain Management, the presence of THC metabolites in the urine of patients undergoing pain management is associated with lower levels of opioids. The post THC in Urine is Associated with Lower Opioid Concentrations In Pain Patients, Finds Study appeared first on TheJointBlog.

Concentrates 48

Concentrates Patients THC Collective 48

Cannabis Law Report

SEPTEMBER 7, 2022

Since the legalisation of medical cannabis in the UK in 2018, there is little education surrounding medical cannabis and how it can help a large variety of conditions, should traditional medicine leave patients with an ‘unmet clinical need.’ .

Patients 52

Patients Conditions Treatment Education 52

Cannabis Law Report

SEPTEMBER 11, 2021

The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.

Compliance 105

Compliance Compliance Seed-To-Sale Data 105

Veriheal

SEPTEMBER 13, 2022

With legalization, patients and consumers have more freedom in product choice, and many are turning to homegrown cannabis. Research from New Frontier Data estimates that around 3 million people grow their own cannabis at home in the United States. Cultivation Costs for Homegrowers. Will you be one of them?

Cultivation 109

Cultivation Data DEA Dispensary 109

Cannabis Law Report

MARCH 27, 2019

New Frontier Data say that they recently presented preliminary findings to the Zimbabwean government while working in collaboration with other regulators in the region to finalize what will be the first “rigorous assessments of both risks and opportunities of hemp cultivation in Africa.” Taxation , CohnReznick (U.S.).

Policy 65

Policy Law Hemp Data 65

Cannabis Law Report

SEPTEMBER 1, 2021

Of note, the number of Independent Testing Laboratories in the Commonwealth increased from three to five in 2021, which the Commission hopes will increase the product supply that is tested, approved, and available to consumers and patients. This past May, the Commission launched the license application for Marijuana Delivery Operators.

Marijuana 100

Marijuana Seed-To-Sale Safety Data 100

Cannabis Law Report

SEPTEMBER 15, 2021

This deceptive marketing of unproven treatments raises significant public health concerns because patients and other consumers may use them instead of approved therapies to treat serious and even fatal diseases. Of the 22 patients, 19 experienced adverse events after ingesting delta-8 THC-containing food products (e.g.,

THC 105

THC Pets Events Hemp 105

MMJ Recs

MARCH 16, 2024

Key factors influencing market size and revenue include patient demographics, regulatory frameworks, product offerings, and pricing strategies. Moreover, ensuring product quality and safety throughout the supply chain is paramount to maintain patient trust and regulatory compliance.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Cannabis Law Report

JANUARY 23, 2022

I did not know what to expect and as well as presenting my first scientific poster, I was gaining my first taste of the academic world. But a few presentations from the week of presentations stood out to me. The team recruited 48 Patients with leukaemia or myelodysplastic syndrome. Graft versus host disease (GVHD).

Research and Development 52

Research and Development Wellness and Beauty Patients CBD 52

Cannabis Law Report

DECEMBER 7, 2021

Dravet syndrome is a rare presentation of intractable epileptic encephalopathies associated with pleomorphic seizure activity, usually before the one year of age, while Lennox-Gastaut syndrome is characterized by multiple drug-resistant seizure with a unique EEG pattern.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

JUNE 30, 2021

Despite the high prevalence of these disorders, few patients are accurately screened and diagnosed. of patients with major depressive disorder, 92.7% of patients with bipolar disorder, 71% of patients with generalized anxiety disorder, and 97.8% of patients with social anxiety disorder. Building the Data Backend.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

The Blunt Truth

FEBRUARY 16, 2024

If he’s presented with a bill, will he veto it? Now the Arkansans for Patient Access have submitted a new version of the initiative, which adds a section prohibiting the state legislature from making changes to the language. The current HHS recommendation to reschedule marijuana lacks both substance and data Rep.

Retail 52

Retail Access Data Marijuana 52

The Joint Blog

DECEMBER 9, 2019

The twice-daily administration of plant-derived CBD-dominant extracts is associated with symptom improvement in adolescents with autism spectrum disorder (ASD), according to observational data published in the journal Frontiers in Neurology.

CBD 49

CBD Extraction Epilepsy Sativa 49

Otherside Farms

JANUARY 25, 2019

Lead author Dr. Tim England, honorary consultant stroke physician at the University of Nottingham and Royal Derby Hospital, presented the findings at this week’s annual UK Stroke Forum conference. The data are guiding the next steps in experimental stroke in order to be able to progress onto initial safety assessments in a clinical trial.”.

Clinical Trials 74

Clinical Trials Marijuana Cannabinoids Data 74

Cannabis Law Report

JUNE 15, 2021

The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.

Compliance 105

Compliance Compliance Seed-To-Sale Data 105

Cannabis Law Report

FEBRUARY 2, 2022

As many patients use cannabis-based medicines to aid with sleep, the current detection window is of significant concern. Alternative tests, such as the LuciX platform from Dutch company Bloonics, are able to provide detailed information about the cannabinoids present in someone’s system, including synthetic cannabinoids. “We

Medicine 52

Medicine Clinical Trials Consumption Sleep 52

Cannabis Law Report

FEBRUARY 25, 2022

The court’s decision came just days before arguments were set to be presented in the case. Ultra Health, one of the state’s largest medical cannabis producers, which had filed the original lawsuits, had not been charging patients taxes, and instead had been absorbing the taxes. In 2020, New Mexico Court of Appeals Judge M.

Programs 52

Programs Collective Data Patients 52

Veriheal

MARCH 29, 2023

The Relationship Between Marijuana Use and Psychosis Using the Optum Clinformatics DataMart Database , which functions as an anonymous Medicare Advantage and commercial claims database, scientists were able to gather data with unprecedented precision. How Several Sources of Data Were Used in the Research In 2019, an estimated 48.2

Legalization 57

Legalization Data Policy Cannabis 57

Veriheal

SEPTEMBER 12, 2022

Not only will cannabis assist with lowering your odds of presenting with this cancer, but it also shows promise as a life-saving treatment option. . Ahmed ElTelbany and colleagues reported that those who have a recent history of cannabis use were “55 percent less likely to have HCC compared to patients without cannabis use.”

Research and Development 57

Research and Development Oil Treatment Patients 57

The Joint Blog

JULY 17, 2020

According to a new study published in the journal Seminars in Pediatric Neurology, marijuana-based products are associated with improvements in the symptoms of autistic patients who have self-injurious behaviors and co-morbid epilepsy. The study is titled Autism Spectrum Disorder and medical cannabis: Review & clinical experience.

Epilepsy 47

Epilepsy Research and Development Marijuana Treatment 47